Next Article in Journal
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver
Next Article in Special Issue
HIPK2 Phosphorylates the Microtubule-Severing Enzyme Spastin at S268 for Abscission
Previous Article in Journal
Mitochondrial DNA Variants and Common Diseases: A Mathematical Model for the Diversity of Age-Related mtDNA Mutations
Previous Article in Special Issue
Cytokinesis D is Mediated by Cortical Flow of Dividing Cells Instead of Chemotaxis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 8
Issue 6
10.3390/cells8060609
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Cell Wall Hydrolytic NlpC/P60 Endopeptidases in Mycobacterial Cytokinesis: A Structural Perspective

by
Flavia Squeglia
†,
Miguel Moreira
†,
Alessia Ruggiero
and
Rita Berisio
*
Institute of Biostructures and Bioimaging (IBB), CNR, 80134 Naples, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cells 2019, 8(6), 609; https://doi.org/10.3390/cells8060609
Submission received: 30 May 2019 / Revised: 12 June 2019 / Accepted: 14 June 2019 / Published: 18 June 2019
(This article belongs to the Special Issue Molecular Factors and Mechanisms Involved in Cytokinesis)
Browse Figures
Versions Notes

Abstract

:
In preparation for division, bacteria replicate their DNA and segregate the newly formed chromosomes. A division septum then assembles between the chromosomes, and the mother cell splits into two identical daughters due to septum degradation. A major constituent of bacterial septa and of the whole cell wall is peptidoglycan (PGN), an essential cell wall polymer, formed by glycan chains of β−(1-4)-linked-N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), cross-linked by short peptide stems. Depending on the amino acid located at the third position of the peptide stem, PGN is classified as either Lys-type or meso-diaminopimelic acid (DAP)-type. Hydrolytic enzymes play a crucial role in the degradation of bacterial septa to split the cell wall material shared by adjacent daughter cells to promote their separation. In mycobacteria, a key PGN hydrolase, belonging to the NlpC/P60 endopeptidase family and denoted as RipA, is responsible for the degradation of septa, as the deletion of the gene encoding for this enzyme generates abnormal bacteria with multiple septa. This review provides an update of structural and functional data highlighting the central role of RipA in mycobacterial cytokinesis and the fine regulation of its catalytic activity, which involves multiple molecular partners.

1. Introduction to Cytokinesis in Bacteria

The bacterial cell division is a complex cell cycle by which a parent cell divides into two daughter cells. This process is characterized by two main events: chromosome segregation and cytokinesis (Figure 1) [1,2]. A single, circular chromosome replicates its DNA and, after replication, the two chromosomes move towards opposite ends of the cell in a process called segregation. After the completion of chromosome segregation, the division process begins with the formation of the septal ring, called Z-ring, a polymer of the tubulin-like GTPase FtsZ, which is almost universally conserved [3,4,5] (Figure 1). The Z-ring is stabilized by FtsA and ZipA (Z-interacting protein A) [6,7]. Subsequently, other protein factors are recruited to the cytokinetic ring, forming a piece of complex machinery called the divisome [8,9].
In Mycobacterium tuberculosis, FtsZ has been recognized as one of the major cytoskeletal organizers of the mycobacterial divisome [10]. Indeed, depletion of FtsZ results in long filamentous cells [4,10]. The mechanisms by which a Z-ring composed of FtsZ subunits contracts remains enigmatic. In M. tuberculosis, it has been proposed that GTP hydrolysis and/or nucleotide release induces a conformational change that alters the intersubunit packing of FtsZ polymer, an event which likely promotes ring contraction [11].
The ring formed by FtsZ recruits both structural and enzymatic proteins involved in peptidoglycan (PGN) synthesis and, thus, in the formation of the septum [12,13]. Then, this septal PGN, initially shared between daughter cells, must be degraded by PGN hydrolases to complete the division process. However, a central problem is to understand how the events of cell division inside the cell send signals that trigger PGN hydrolysis by hydrolases outside the cell. A currently accepted model is that FtsE and FtsX sense the progress of cell division and regulate extracellular PGN hydrolases. Of these, FtsE links the Z-ring to the transmembrane protein, FtsX, which senses the PGN hydrolases outside the cell [14]. More specifically, FtsE hydrolyzes ATP to ADP upon sensing an unknown signal from inside the cell. This hydrolysis causes a conformational change that is transmitted through the membrane via FtsX. A conformational change of the extracellular part of FtsX results in an interaction with either cell wall hydrolases or effector proteins and activation of PGN hydrolysis [15].
In Escherichia coli, FtsX controls the activity of the PGN amidases AmiA and AmiB through interactions with the effector protein EnvC [16], whereas in Streptococcus pneumoniae, FtsX is known to interact with PcsB, a putative CHAP (Cys, His, Asp peptidase) protein predicted to hydrolyze PGN cross-links [17]. In mycobacteria, several PGN hydrolases have been discovered in recent years, including (i) one N-acetylmuramoyl-L-alanine amidase [18,19]; (ii) five homologous endopeptidases of the NlpC/P60 family, among which RipA plays a central role [20,21,22]; and (iii) a set of five homologous glycosidases, named resuscitation-promoting factors, RpfA-E, which are known to be involved in mycobacterial resuscitation from dormancy [23,24,25]. This work will review structural and functional data related to PGN hydrolases involved in cell division and the complex mechanism of regulation of PGN hydrolysis in mycobacteria.

2. The Peptidoglycan Nature of The Septal Ring

The cell envelope of the M. tuberculosis plays a key role in bacterial virulence and antibiotic resistance, although there is still a lot to discover about the molecular mechanisms of regulation of cell-envelope formation. Since it is unique among prokaryotes, its proteins, carbohydrate, and lipid components have been the subject of interest for developing new vaccines [26,27,28,29]. The molecular and architectural complexity of the mycobacterial cell wall is strictly related to the pathogenicity of the bacterium [30,31]. The uncommon impermeable properties of the M. tuberculosis cell wall and the richness in high molecular weight lipids provide a thick layer involved in M. tuberculosis resistance to antibiotics and stressful conditions [32].
M. tuberculosis cell envelope is made up of three parts: the plasma membrane, the cell wall core, and the capsule. The cell wall core consists of two parts, named as lower and upper segments. The lower segment is composed of an impermeable layer of mycolic acids (MA) connected to a peptidoglycan layer through arabinogalactans (AG) (Figure 2A) [26]. This mycolyl-arabinogalactan-peptidoglycan (mAGP) complex is crucial for the viability of M. tuberculosis and it is important for cell wall integrity and osmotic stability [26]. The upper segment, also named as outer membrane, contains proteins, sulfolipids, phosphatidylinositol mannosides (PIMs), phthiocerol-containing lipids, lipomannan (LM), lipoarabinomannan (LAM), and mycolic acids esters, principally trehalose-6,6-dimycolate (TDM) and trehalose mono-mycolate (TMM) (Figure 2A) [27,28,29]. Several studies have shown that PIMs, LM, and LAM exhibit important and distinct immunomodulatory properties. Indeed, they regulate the production and secretion of pro-inflammatory cytokines during mycobacterial phagocytosis by macrophages [26,28,33]. The most cell-surface-exposed material is composed of capsular polysaccharides, proteins, and small amounts of lipids [34,35]. Surface proteins and polysaccharides are responsible for adhesion, penetration, infection, and survival of M. tuberculosis in the host cells [36,37,38,39,40].
PGN is an essential and dynamic element of the mycobacterial cell wall. Its biosynthesis is targeted by many potent antibiotics and several enzymes involved in cell division final process, due to its abundance at the bacterial septal ring [41,42,43]. It is a polymer composed of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues, linked in a β(1→4) configuration [44]. These glycan strands are cross-linked by short peptides containing peculiar amino acids, for example d-Ala, d-Glu and meso-diaminopimelic acid (DAP) (Figure 2B).

3. Septal Ring Degradation and Daughter Cell Division

Septal PGN is initially shared between daughter cells and must be degraded by PGN hydrolases to complete the division process. Bacterial cellular division ends with cell disconnection, a mechanism needed to disconnect the two new daughter sacculi after the cell division is completed, or at the very late step of cell division. The process of daughter cell separation requires a delicate balance of cell wall hydrolases that cleave the septa connecting the daughter cells. Cell-separating enzymes usually contain endopeptidase domains, like cysteine histidine aminopeptidase (CHAP) or NLPC/P60 domains, and/or glucosaminidase domains [45,46,47]. Interestingly, as many as 18 hydrolases are known to be involved in septum cleavage of E. coli, while only a few hydrolases are known in mycobacteria [41,42,48] (Table 1).
As described above, five NlpC/P60 proteins are predicted to be secreted by M. tuberculosis, although Rv0024 lacks a recognizable signal peptide (SP). RipA (Rv1477), RipB (Rv1478), RipC (Rv2190c), and Rv0024 show the typical architecture, with the catalytic domain at the C-terminus (Figure 3). Differently, RipD (Rv1566c) encodes an N-terminal catalytic domain. This domain does not show peptidoglycan hydrolase activity, which is consistent with the sequence alterations at the catalytic site [52]. RipA and RipB contain pro-domains just before the catalytic domain, which were shown to inactivate the enzymes [20,51]. In contrast, the RipC catalytic domain is preceded by a proline-rich linker with no inactivating function [57]. In addition, both RipA and RipC contain a predicted N-terminal coiled-coil domain (Figure 3).
RipA is the largest and more complex endopeptidase. It is a key enzyme for M. tuberculosis cell division, with remarkable effects on the bacterial phenotype, as shown in M. smegmatis. Indeed, RipA depletion strains exhibit a decreasing growth and an abnormal phenotype, consisting of branching and chaining bacteria [58]. Similar to other cell separating endopeptidases, like CwlT from Bacillus subtilis [59] and Spr from E. coli [60], RipA hydrolyzes peptidoglycan peptide crosslinks [21].
Crystallographic studies of RipA first [20] and then of RipB [51] have yielded new insights into the functional regulation of these enzymes. The structure of RipA catalytic domain comprises a central β-sheet of six antiparallel β-strands, a small two-stranded β-sheet, and six helices, arranged in an αββααββββββ topology (Figure 4). Its putative catalytic cysteine (Cys383) is located at the N-terminal end of a helix (α2) and is packed against the six-stranded β-sheet core (Figure 4). At this location, Cys383 facets another conserved residue, His432, belonging to the β-strand β3 (Figure 4). This histidine is hydrogen bonded to the side chain of Glu444, which is, in turn, tightly anchored to Arg453 and Arg458 (Figure 4). Notably, the crystal structure suggested a Cys-His-Glu catalytic triad, which is unusual considering the typical Cys-His-His triad of NlpC/P60 endopeptidases (Figure 4) [20].
The composition of this triad was confirmed by mutational studies, as the mutation of each residue of the triad to alanine completely suppresses RipA activity [49]. As shown in Figure 5, the catalytic site cleft shape accounts well for the branched nature of peptidoglycan, whose monomer has the structure GlcNAc-MurNAc-L-Ala-γ-D-Glu-DAP-D-Ala. Aside from the catalytic triad, several residues interact with the muropeptide (D382, S384, S402, V428, Q431, D447) (Figure 5). Among these, the most conserved is D382, which directly contacts γ-D-Glu; this indicates a strong specificity of RipA towards γ-D-Glu [49]. Differently, scarce conservation characterizes residues contacting DAP side chain (e.g., D447), a finding that agrees well with the ability of RipA to hydrolyze both Lys-type and DAP-type PGN [20].
Structural studies also showed that a tight array of interactions exist between the catalytic domain and the pro-domain [20]. In particular, the catalytic site cleft of the enzyme is physically blocked by the pro-domain, which contains a catalytic-cleft-blocking loop region, a β hairpin, and a long α helix, nearly perpendicular to the β hairpin (Figure 6). A tight interaction is observed between these two domains, with a total interaction surface area of 1809 Å2 [20]. This finding strongly suggested functional inactivity of the enzyme in this form and revealed a zymogenic nature for RipA. Consistently, cell wall degradation assays showed that activation of RipA requires the release of the pro-domain [20]. A strong structural conservation was observed for the catalytic domains of RipA and RipB, whereas structural differences characterized the pro-domains. In RipB, the pro-domain is folded in two helices wrapped around the catalytic domain, suggesting a similar regulatory function as observed for RipA [51]. Compared to RipB, RipA contains an extra N-terminal domain, whose structure has been recently determined [50] (PDB code 6ewy). This domain is formed by two helices of similar length, connected by a 6-residue loop, and forms a long-coiled coil structure (Figure 6). Whereas the pro-domain of RipA has a regulating function, its helical domain does not influence the accessibility of the active site (Figure 6). Instead, its rigid stalk-like module is typical of scaffold building proteins. Possibly, this non-catalytic domain is responsible for anchoring the enzyme to the divisome, although interactions of RipA with the divisome have so far not been demonstrated [50]. Different from RipA, the homologue NlpC/P60 endopeptidase RipC interacts with FtsX [57], and this interaction favors a long-range conformational change that activates RipC [15,57] (Figure 7). As observed for other bacteria, hydrolysis of ATP by FtsE is believed to cause a conformational change that is transmitted through the membrane via FtsX to the extracellular region [15]. In M. tuberculosis, the conformational change of the extracellular part of FtsX results in interaction with RipC, an event which causes RipC conformational activation [57] (Figure 7). It should be noted that RipC does not contain an inactivating pro-domain, different than RipA and RipB (Figure 3). Therefore, it is likely that its mechanism of activation differs from those of RipA and RipB. In these latter cases, the tight interaction of the catalytic sites with the pro-domains is in line with an alternative activation mechanism, which requires proteolytic activation [20,22]. Although studies are still to be undertaken, it is presumable, as demonstrated for RipC, that, in all cases, a coordinated mechanism exists that regulates Z-ring formation by FtsZ, septation, and septum degradation.

3.1. The Regulation of RipA Through MarP

As previously discussed, structural and biochemical studies have suggested that RipA needs to be proteolytically processed to achieve hydrolysis activity [20]. A proteolytic activation mechanism has been successively confirmed in vivo [22]. In addition, it has been shown that overproduction of activated RipA produces severe growth defects in M. tuberculosis [22]. More recently, RipA has been demonstrated to be the substrate of MarP (Mycobacterium acid resistance protease, Rv3671c), a serine protease which has been associated to the resistance of M. tuberculosis to the acidic conditions of phagolysosomes [61]. MarP is a highly conserved protein in mycobacteria, required for pH homeostasis and survival in a hostile environment [62,63]. Its N-terminal domain includes four putative transmembrane helices that likely anchor the protease to the cytoplasmic membrane [64]. The chymotrypsin-like serine protease domain of MarP is located at its C-terminus and contains the catalytic triad, composed of His235, Asp264, and Ser343, conserved in the serine protease family (PDB code 3k6y) [65]. With this topology, the C-terminal protease domain is placed in a periplasmic localization, essential to exert its hydrolytic function on RipA (Figure 8). Indeed, biochemical studies have demonstrated that these two proteins interact in vivo in acidic conditions [61].
Interestingly, M. tuberculosis cells that lack MarP are hypersensitive to acidic pH [66] and share similar phenotypes as cells lacking RipA. Indeed, both mutants display increased cell length and form chains in acidic conditions [61]. These data indicate that the inability of MarP-deficient cells to survive acidic stress depends on their inability to activate RipA, and that PGN hydrolysis is essential for M. tuberculosis survival in acidic conditions [61]. In these conditions, activation of RipA by MarP assures PGN remodeling, rearrangement, or repair, all steps which are likely vital to the survival of M. tuberculosis during acidic stress. It should be noted that the identified site of RipA hydrolysis by MarP is specifically located after Val235, which belongs to the N-terminal domain of RipA (Figure 8). This cleavage does not unlock the catalytic cleft of RipA, which remains occluded by the regulatory domain (Figure 8). However, the release of RipA from its stalk N-terminal domain likely exposes the enzyme to other proteases for the fine processing that activates RipA for PGN degradation. Also, it cannot be excluded that activation of RipA in non-acidic stress conditions may be regulated by other proteases. In addition, it is still to be established what the link is between septation through the assembly of the Z-ring and PGN hydrolysis by RipA, as no interactions between these two processes have yet to been proven.

3.2. Regulation of RipA Via Protein-Protein Interactions

RipA was identified as a protein localized in the septum of dividing mycobacteria and was proposed to be part of the divisome [41]. RipA has a wide pattern of interactors (Figure 9). Besides being cleaved by MarP, RipA was shown to interact with a pool of PGN modeling enzymes, including the resuscitation-promoting factors RpfB (Rv1009) and RpfE (Rv2450c), and the penicillin-binding protein PonA1 (Rv0050) [67,68]. In addition, RipA is able to interact with MoxR1, a member of the ATPase family that is associated with various cellular activities. MoxR1 protein displays ATP-enhanced chaperone activity and MoxR1-mediated folding of RipA is critical for its secretion within the TAT pathway system [69].
Interestingly, a strong connection exists between cell division and resuscitation from the dormant state, characterized by low metabolic activity and resistance to antibiotics [70,71,72]. A latent infection, due to dormant bacteria, can develop into active disease even decades after initial infection, when the immune response weakens [73,74]. Since about one-third of the world’s population is infected with dormant M. tuberculosis, the risk of disease reactivation is troublesome. Resuscitation from the dormant state is attributed to a set of PGN hydrolases, denoted as resuscitation-promoting factors (Rpfs) [70,75,76,77,78,79,80]. RipA co-localizes at bacterial septa with the resuscitation-promoting factor RpfB [67], which exhibits the highest structural complexity among the five Rpfs. Whereas RpfA, RpfC, RpfD, and RpfE are mainly composed of a lysozyme-like catalytic domain, RpfB contains a further four domains: a G5 domain and three DUF348 domains, in addition to the catalytic domain. Structural studies of RpfB have been crucial to elucidate the functional features of this molecule [24,25,53,81].
Similar to lysozyme, the protein catalytic cleft consists of six carbohydrate-binding sites (A–F), thus, corroborating the hypothesis that RpfB acts by hydrolyzing the carbohydrate component of PGN [53]. Crystallographic studies have also evidenced a novel fold of the G5 domain, constituted by two β-sheets connected by a small triple helix motif, and denominated as β-TH-β [25], which has been connected to PGN adhesion [25]. Also, the structural description of the DUF348 domain revealed an unexpected structural similarity to eukaryotic ubiquitin, a small protein that exists in all eukaryotic cells both to target proteins for rapid degradation by the proteasome [24]. The presence of an ubiquitin-like domain in RpfB may be responsible for its ability to interact with several proteins, by sharing a strong feature of ubiquitin: its promiscuity due to its intrinsic high molecular adaptability [82]. PGN hydrolase activities of RipA and RpfB are synergic although the structural basis of this synergistic action is hitherto not clear [21], as it may either be associated with the allosteric activation of one of these proteins or to their enhanced ability to release free muropeptides by acting both on the glycan and peptide moieties [83]. Along this line, it has been shown that the joint action of RpfB and RipA on PGN produces a reaction product of particular chemical nature, anhydroGMDP, which directly induces resuscitation of the dormant cell cultures [83]. This finding also agrees well with the previous finding, showing that resuscitation from dormancy is a complex phenomenon, involving direct interaction of muropeptides released upon PGN hydrolysis with a set of STPK kinases [40,84,85,86,87,88,89]. Interestingly, the synergy between hydrolytic actions RipA and RpfB of PGN can be inhibited by the interaction of RipA with the penicillin-binding protein PonA1, a key PGN synthase, which also co-localizes at the poles and septa of dividing cells and is a central determinant of polar growth in mycobacteria [68,90]. This finding indicates universal molecular mechanisms that coordinate cell wall synthesis and degradation through protein-protein interactions between enzymes with antagonistic functions.

4. Concluding Remarks

As discussed in this review, cytokinesis is regulated in M. tuberculosis by a set of endopeptidases of the NlpC/P60 family. Similar to other cases of proteins responsible for key cell processes, a high redundancy characterizes these enzymes, since five endopeptidases are encoded in the mycobacterial genome. However, the reason for the existence of these redundant enzymes, sharing a similar structure, remains elusive. NlpC/P60 endopeptidases are potentially suicide enzymes since they are able to hydrolyze the mycobacterial cell wall. Consistently, their catalytic activities are strongly regulated. Among these NlpC/P60 endopeptidases, RipA plays a central role, as it is essential to cleave the mycobacterial PGN septum, which is synthesized right after chromosome segregation. The data accumulated in recent years concerning the main endopeptidases structure and function provided a more detailed picture of their catalytic and regulatory mechanisms. In RipA, catalytic regulation proceeds both through proteolytic cleavage and through the interaction with multiple molecular partners. Differently, activation of its homolog RipC proceeds through a conformational alteration due to interactions with the divisome protein FtsX. Going forward, it will be important to define in more detail which mechanisms correlate septal PGN formation following Z-ring formation with PGN degradation.
Recent studies have shown that the use of hydrolases, such as RipA, alters the physiological state and induces stress responses in M. smegmatis, but it does not completely inhibit mycobacterial growth [91]. However, when used in conjugation with common antimicrobial drugs, such as rifabutin and bacitracin, RipA enhances their cytotoxic activities. This finding brings further advantages for drug development and antimicrobial treatment, as it highlights the potential for a new strategy that combines endopeptidases with previously ineffective drugs against drug-resistant bacteria.

Author Contributions

Conceptualization, R.B. and F.S.; methodology, R.B.; software, M.M.; validation, F.S., M.M. and A.R.; formal analysis, F.S. and M.M; investigation, F.S.; resources, R.B.; data curation, R.B.; writing—original draft preparation, F.S.; writing—review and editing, R.B.; visualization, M.M.; supervision, R.B.; project administration, R.B.; funding acquisition, R.B.

Funding

This research was funded by MIUR PRIN project “An integrated approach to tackle the interplay among adaptation, stressful conditions and antimicrobial resistance of challenging pathogens”, GA 2017SFBFER, 2019-2022.

Acknowledgments

We would like to acknowledge the help of our technical staff, including Maurizio Amendola and Luca De Luca.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

AGarabinogalactans
AnhydroGMDPN-acetylglucosaminyl-β(1→4)-N-acetyl-1,6-anhydromuramoyl-l-alanyl-d-isoglutamate
CHAPCys, His, Asp Peptidase
DAPmeso-diaminopimelic acid
Ftsfilamenting temperature-sensitive
GlcNAcβ−(1-4)-linked-N-acetylglucosamine
LMlipomannan
LAMlipoarabinomannan
MAmycolic acids
MurNAcN-acetylmuramic acid
PDBProtein Databank
PGNpeptidoglycan
PIMsphosphatidylinositol mannosides
Ripresuscitation-promoting factor interacting protein
Rpfresuscitation-promoting factor
SPsignal peptide
STPKSerine/Threonine Protein Kinase
TATTwin-Arginine Translocation

References

  1. Errington, J.; Daniel, R.A.; Scheffers, D.J. Cytokinesis in bacteria. Microbiol. Mol. Biol. Rev. 2003, 67, 52–65. [Google Scholar] [CrossRef] [PubMed]
  2. He, Z.; Guo, K.K. Exploration of cell division times during bacterial cytokinesis. Phys. Chem. Chem. Phys. 2017, 19, 32038–32046. [Google Scholar] [CrossRef] [PubMed]
  3. Dajkovic, A.; Lutkenhaus, J. Z ring as executor of bacterial cell division. J. Mol. Microbiol. Biotechnol. 2006, 11, 140–151. [Google Scholar] [CrossRef]
  4. Lutkenhaus, J.F.; Wolf-Watz, H.; Donachie, W.D. Organization of genes in the ftsA-envA region of the Escherichia coli genetic map and identification of a new fts locus (ftsZ). J. Bacteriol. 1980, 142, 615–620. [Google Scholar] [PubMed]
  5. Lariviere, P.J.; Mahone, C.R.; Santiago-Collazo, G.; Howell, M.; Daitch, A.K.; Zeinert, R.; Chien, P.; Brown, P.J.B.; Goley, E.D. An Essential Regulator of Bacterial Division Links FtsZ to Cell Wall Synthase Activation. Curr. Biol. 2019, 29, 1460–1470. [Google Scholar] [CrossRef] [PubMed]
  6. Pazos, M.; Peters, K.; Casanova, M.; Palacios, P.; VanNieuwenhze, M.; Breukink, E.; Vicente, M.; Vollmer, W. Z-ring membrane anchors associate with cell wall synthases to initiate bacterial cell division. Nat. Commun. 2018, 9, 5090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Vega, D.E.; Margolin, W. Direct Interaction between the Two Z Ring Membrane Anchors FtsA and ZipA. J. Bacteriol. 2019, 201, e00579-18. [Google Scholar] [CrossRef] [PubMed]
  8. Lutkenhaus, J.; Pichoff, S.; Du, S.S. Bacterial cytokinesis: From Z ring to divisome. Cytoskeleton 2012, 69, 778–790. [Google Scholar] [CrossRef]
  9. den Blaauwen, T.; Luirink, J. Checks and Balances in Bacterial Cell Division. MBio 2019, 10. [Google Scholar] [CrossRef] [PubMed]
  10. Turner, D.J.; Portman, I.; Dafforn, T.R.; Rodger, A.; Roper, D.I.; Smith, C.J.; Turner, M.S. The mechanics of FtsZ fibers. Biophys. J. 2012, 102, 731–738. [Google Scholar] [CrossRef] [PubMed]
  11. Leung, A.K.W.; White, E.L.; Ross, L.J.; Reynolds, R.C.; DeVito, J.A.; Borhani, D.W. Structure of Mycobacterium tuberculosis FtsZ reveals unexpected, G protein-like conformational switches. J. Mol. Biol. 2004, 342, 953–970. [Google Scholar] [CrossRef] [PubMed]
  12. Margolin, W. FtsZ and the division of prokaryotic cells and organelles. Nat. Rev. Mol. Cell Biol. 2005, 6, 862–871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Perez, A.J.; Cesbron, Y.; Shaw, S.L.; Bazan Villicana, J.; Tsui, H.-C.T.; Boersma, M.J.; Ye, Z.A.; Tovpeko, Y.; Dekker, C.; Holden, S.; et al. Movement dynamics of divisome proteins and PBP2x:FtsW in cells of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 2019, 116, 3211–3220. [Google Scholar] [CrossRef]
  14. Mir, M.A.; Arumugam, M.; Mondal, S.; Rajeswari, H.S.; Ramakumar, S.; Ajitkumar, P. Mycobacterium tuberculosis Cell Division Protein, FtsE, is an ATPase in Dimeric Form. Protein J. 2015, 34, 35–47. [Google Scholar] [CrossRef] [PubMed]
  15. Rued, B.E.; Alcorlo, M.; Edmonds, K.A.; Martinez-Caballero, S.; Straume, D.; Fu, Y.; Bruce, K.E.; Wu, H.W.; Havarstein, L.S.; Hermoso, J.A.; et al. Structure of the Large Extracellular Loop of FtsX and Its Interaction with the Essential Peptidoglycan Hydrolase PcsB in Streptococcus pneumoniae. MBio 2019, 10. [Google Scholar] [CrossRef] [PubMed]
  16. Yang, D.C.; Peters, N.T.; Parzych, K.R.; Uehara, T.; Markovski, M.; Bernhardt, T.G. An ATP-binding cassette transporter-like complex governs cell-wall hydrolysis at the bacterial cytokinetic ring. Proc. Natl. Acad. Sci. USA 2011, 108, E1052–E1060. [Google Scholar] [CrossRef] [PubMed]
  17. Bartual, S.G.; Straume, D.; Stamsas, G.A.; Munoz, I.G.; Alfonso, C.; Martinez-Ripoll, M.; Havarstein, L.S.; Hermoso, J.A. Structural basis of PcsB-mediated cell separation in Streptococcus pneumoniae. Nat. Commun. 2014, 5. [Google Scholar] [CrossRef] [PubMed]
  18. Kumar, A.; Kumar, S.; Kumar, D.; Mishra, A.; Dewangan, R.P.; Shrivastava, P.; Ramachandran, S.; Taneja, B. The structure of Rv3717 reveals a novel amidase from Mycobacterium tuberculosis. Acta Crystallogr. D Biol. Crystallogr. 2013, 69, 2543–2554. [Google Scholar] [CrossRef] [PubMed]
  19. Prigozhin, D.M.; Mavrici, D.; Huizar, J.P.; Vansell, H.J.; Alber, T. Structural and biochemical analyses of Mycobacterium tuberculosis N-acetylmuramyl-L-alanine amidase Rv3717 point to a role in peptidoglycan fragment recycling. J. Biol. Chem. 2013, 288, 31549–31555. [Google Scholar] [CrossRef]
  20. Ruggiero, A.; Marasco, D.; Squeglia, F.; Soldini, S.; Pedone, E.; Pedone, C.; Berisio, R. Structure and Functional Regulation of RipA, a Mycobacterial Enzyme Essential for Daughter Cell Separation. Structure 2010, 18, 1184–1190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Hett, E.C.; Chao, M.C.; Deng, L.L.; Rubin, E.J. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog. 2008, 4. [Google Scholar] [CrossRef] [PubMed]
  22. Chao, M.C.; Kieser, K.J.; Minami, S.; Mavrici, D.; Aldridge, B.B.; Fortune, S.M.; Alber, T.; Rubin, E.J. Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria. PLoS Pathog. 2013, 9, e1003197. [Google Scholar] [CrossRef] [PubMed]
  23. Ruggiero, A.; Marchant, J.; Squeglia, F.; Makarov, V.; De Simone, A.; Berisio, R. Molecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosis. J. Biomol. Struct. Dyn. 2013, 31, 195–205. [Google Scholar] [CrossRef] [PubMed]
  24. Ruggiero, A.; Squeglia, F.; Romano, M.; Vitagliano, L.; De Simone, A.; Berisio, R. The structure of Resuscitation promoting factor B from M. tuberculosis reveals unexpected ubiquitin-like domains. Bba-Gen. Subj. 2016, 1860, 445–451. [Google Scholar] [CrossRef] [PubMed]
  25. Ruggiero, A.; Tizzano, B.; Pedone, E.; Pedone, C.; Wilmanns, M.; Berisio, R. Crystal Structure of the Resuscitation-Promoting Factor (Delta DUF)RpfB from M. tuberculosis. J. Mol. Biol. 2009, 385, 153–162. [Google Scholar] [CrossRef] [PubMed]
  26. Alderwick, L.J.; Harrison, J.; Lloyd, G.S.; Birch, H.L. The Mycobacterial Cell Wall-Peptidoglycan and Arabinogalactan. Cold Spring Harbor Perspect. Med. 2015, 5. [Google Scholar] [CrossRef] [PubMed]
  27. Sarmiento, M.E.; Alvarez, N.; Chin, K.L.; Bigi, F.; Tirado, Y.; Garcia, M.A.; Anis, F.Z.; Norazmi, M.N.; Acosta, A. Tuberculosis vaccine candidates based on mycobacterial cell envelope components. Tuberculosis 2019, 115, 26–41. [Google Scholar] [CrossRef]
  28. Brennan, P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 2003, 83, 91–97. [Google Scholar] [CrossRef]
  29. Mishra, A.K.; Driessen, N.N.; Appelmelk, B.J.; Besra, G.S. Lipoarabinomannan and related glycoconjugates: Structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. Fems Microbiol. Rev. 2011, 35, 1126–1157. [Google Scholar] [CrossRef]
  30. Glickman, M.S.; Cox, J.S.; Jacobs, W.R. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 2000, 5, 717–727. [Google Scholar] [CrossRef]
  31. Dubnau, E.; Chan, J.; Raynaud, C.; Mohan, V.P.; Laneelle, M.A.; Yu, K.M.; Quemard, A.; Smith, I.; Daffe, M. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 2000, 36, 630–637. [Google Scholar] [CrossRef] [PubMed]
  32. Takayama, K.; Wang, C.; Besra, G.S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2005, 18, 81–101. [Google Scholar] [CrossRef] [PubMed]
  33. Kallenius, G.; Correia-Neves, M.; Buteme, H.; Hamasur, B.; Svenson, S.B. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations. Tuberculosis 2016, 96, 120–130. [Google Scholar] [CrossRef] [PubMed]
  34. Lemassu, A.; Daffe, M. Structural Features of the Exocellular Polysaccharides of Mycobacterium-Tuberculosis. Biochem. J. 1994, 297, 351–357. [Google Scholar] [CrossRef] [PubMed]
  35. Ortalomagne, A.; Dupont, M.A.; Lemassu, A.; Andersen, A.B.; Gounon, P.; Daffe, M. Molecular Composition of the Outermost Capsular Material of the Tubercle Bacillus. Microbiology 1995, 141, 1609–1620. [Google Scholar] [CrossRef]
  36. Daffe, M.; Etienne, G. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tubercle Lung Dis. 1999, 79, 153–169. [Google Scholar] [CrossRef]
  37. Esposito, C.; Cantisani, M.; D’Auria, G.; Falcigno, L.; Pedone, E.; Galdiero, S.; Berisio, R. Mapping key interactions in the dimerization process of HBHA from Mycobacterium tuberculosis, insights into bacterial agglutination. FEBS Lett. 2012, 586, 659–667. [Google Scholar] [CrossRef]
  38. Esposito, C.; Carullo, P.; Pedone, E.; Graziano, G.; Del Vecchio, P.; Berisio, R. Dimerisation and structural integrity of Heparin Binding Hemagglutinin A from Mycobacterium tuberculosis: Implications for bacterial agglutination. FEBS Lett. 2010, 584, 1091–1096. [Google Scholar] [CrossRef]
  39. Esposito, C.; Marasco, D.; Delogu, G.; Pedone, E.; Berisio, R. Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation. Biochem. Biophys. Res. Commun. 2011, 410, 339–344. [Google Scholar] [CrossRef]
  40. Squeglia, F.; Ruggiero, A.; De Simone, A.; Berisio, R. A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeutics. Protein Sci. 2018, 27, 369–380. [Google Scholar] [CrossRef]
  41. Kieser, K.J.; Rubin, E.J. How sisters grow apart: Mycobacterial growth and division. Nat. Rev. Microbiol. 2014, 12, 550–562. [Google Scholar] [CrossRef] [PubMed]
  42. Squeglia, F.; Ruggiero, A.; Berisio, R. Chemistry of Peptidoglycan in Mycobacterium tuberculosis Life Cycle: An off-the-wall Balance of Synthesis and Degradation. Chem.-Eur. J. 2018, 24, 2533–2546. [Google Scholar] [CrossRef] [PubMed]
  43. Squeglia, F.; Romano, M.; Ruggiero, A.; Berisio, R. Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall. Curr. Med. Chem. 2017, 24, 3954–3969. [Google Scholar] [CrossRef] [PubMed]
  44. Lederer, E.; Adam, A.; Ciorbaru, R.; Petit, J.F.; Wietzerbin, J. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol. Cell. Biochem. 1975, 7, 87–104. [Google Scholar] [CrossRef] [PubMed]
  45. Layec, S.; Decaris, B.; Leblond-Bourget, N. Diversity of Firmicutes peptidoglycan hydrolases and specificities of those involved in daughter cell separation. Res. Microbiol. 2008, 159, 507–515. [Google Scholar] [CrossRef]
  46. Layec, S.; Gerard, J.; Legue, V.; Chapot-Chartier, M.P.; Courtin, P.; Borges, F.; Decaris, B.; Leblond-Bourget, N. The CHAP domain of Cse functions as an endopeptidase that acts at mature septa to promote Streptococcus thermophilus cell separation. Mol. Microbiol. 2009, 71, 1205–1217. [Google Scholar] [CrossRef] [PubMed]
  47. Rossi, P.; Aramini, J.M.; Xiao, R.; Chen, C.X.; Nwosu, C.; Owens, L.A.; Maglaqui, M.; Nair, R.; Fischer, M.; Acton, T.B.; et al. Structural elucidation of the Cys-His-Glu-Asn proteolytic relay in the secreted CHAP domain enzyme from the human pathogen Staphylococcus saprophyticus. Proteins 2009, 74, 515–519. [Google Scholar] [CrossRef]
  48. Baranowski, C.; Rego, E.H.; Rubin, E.J. The Dream of a Mycobacterium. Microbiol. Spectr. 2019, 7. [Google Scholar] [CrossRef]
  49. Squeglia, F.; Ruggiero, A.; Romano, M.; Vitagliano, L.; Berisio, R. Mutational and structural study of RipA, a key enzyme in Mycobacterium tuberculosis cell division: Evidence for the L-to-D inversion of configuration of the catalytic cysteine. Acta Crystallogr. D 2014, 70, 2295–2300. [Google Scholar] [CrossRef]
  50. Steiner, E.M.; Lyngso, J.; Guy, J.E.; Bourenkov, G.; Lindqvist, Y.; Schneider, T.R.; Pedersen, J.S.; Schneider, G.; Schnell, R. The structure of the N-terminal module of the cell wall hydrolase RipA and its role in regulating catalytic activity. Proteins-Struct. Funct. Bioinform. 2018, 86, 912–923. [Google Scholar] [CrossRef]
  51. Both, D.; Schneider, G.; Schnell, R. Peptidoglycan Remodeling in Mycobacterium tuberculosis: Comparison of Structures and Catalytic Activities of RipA and RipB. J. Mol. Biol. 2011, 413, 247–260. [Google Scholar] [CrossRef] [PubMed]
  52. Both, D.; Steiner, E.M.; Izumi, A.; Schneider, G.; Schnell, R. RipD (Rv1566c) from Mycobacterium tuberculosis: Adaptation of an NlpC/p60 domain to a non-catalytic peptidoglycan-binding function. Biochem. J. 2014, 457, 33–41. [Google Scholar] [CrossRef] [PubMed]
  53. Squeglia, F.; Romano, M.; Ruggiero, A.; Vitagliano, L.; De Simone, A.; Berisio, R. Carbohydrate Recognition by RpfB from Mycobacterium tuberculosis Unveiled by Crystallographic and Molecular Dynamics Analyses. Biophys. J. 2013, 104, 2530–2539. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Chauviac, F.X.; Robertson, G.; Quay, D.H.X.; Bagneris, C.; Dumas, C.; Henderson, B.; Ward, J.; Keep, N.H.; Cohen-Gonsaud, M. The RpfC (Rv1884) atomic structure shows high structural conservation within the resuscitation-promoting factor catalytic domain. Acta Crystallogr. F 2014, 70, 1022–1026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Maione, V.; Ruggiero, A.; Russo, L.; De Simone, A.; Pedone, P.V.; Malgieri, G.; Berisio, R.; Isernia, C. NMR Structure and Dynamics of the Resuscitation Promoting Factor RpfC Catalytic Domain. PLoS ONE 2015, 10. [Google Scholar] [CrossRef]
  56. Mavrici, D.; Prigozhin, D.M.; Alber, T. Mycobacterium tuberculosis RpfE crystal structure reveals a positively charged catalytic cleft. Protein Sci. 2014, 23, 481–487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Mavrici, D.; Marakalala, M.J.; Holton, J.M.; Prigozhin, D.M.; Gee, C.L.; Zhang, Y.J.J.; Rubin, E.J.; Alber, T. Mycobacterium tuberculosis FtsX extracellular domain activates the peptidoglycan hydrolase, RipC. Proc. Natl. Acad. Sci. USA 2014, 111, 8037–8042. [Google Scholar] [CrossRef]
  58. Hett, E.C.; Rubin, E.J. Bacterial growth and cell division: A mycobacterial perspective. Microbiol. Mol. Biol. Rev. 2008, 72, 126–156. [Google Scholar] [CrossRef]
  59. Fukushima, T.; Kitajima, T.; Yamaguchi, H.; Ouyang, Q.; Furuhata, K.; Yamamoto, H.; Shida, T.; Sekiguchi, J. Identification and characterization of novel cell wall hydrolase CwlT: A two-domain autolysin exhibiting n-acetylmuramidase and DL-endopeptidase activities. J. Biol. Chem. 2008, 283, 11117–11125. [Google Scholar] [CrossRef]
  60. Aramini, J.M.; Rossi, P.; Huang, Y.J.; Zhao, L.; Jiang, M.; Maglaqui, M.; Xiao, R.; Locke, J.; Nair, R.; Rost, B.; et al. Solution NMR structure of the NlpC/P60 domain of lipoprotein Spr from Escherichia coli: Structural evidence for a novel cysteine peptidase catalytic triad. Biochemistry 2008, 47, 9715–9717. [Google Scholar] [CrossRef]
  61. Botella, H.; Vaubourgeix, J.; Lee, M.H.; Song, N.; Xu, W.Z.; Makinoshima, H.; Glickman, M.S.; Ehrt, S. Mycobacterium tuberculosis protease MarP activates a peptidoglycan hydrolase during acid stress. Embo J. 2017, 36, 536–548. [Google Scholar] [CrossRef] [PubMed]
  62. Ribeiro-Guimaraes, M.L.; Tempone, A.J.; Amaral, J.J.; Nery, J.A.; Gomes Antunes, S.L.; Pessolani, M.C. Expression analysis of proteases of Mycobacterium leprae in human skin lesions. Microb. Pathog. 2007, 43, 249–254. [Google Scholar] [CrossRef] [PubMed]
  63. Small, J.L.; O’Donoghue, A.J.; Boritsch, E.C.; Tsodikov, O.V.; Knudsen, G.M.; Vandal, O.; Craik, C.S.; Ehrt, S. Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis. J. Biol. Chem. 2013, 288, 12489–12499. [Google Scholar] [CrossRef] [PubMed]
  64. Sonnhammer, E.L.; von Heijne, G.; Krogh, A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol. 1998, 6, 175–182. [Google Scholar] [PubMed]
  65. Biswas, T.; Small, J.; Vandal, O.; Odaira, T.; Deng, H.; Ehrt, S.; Tsodikov, O.V. Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress. Structure 2010, 18, 1353–1363. [Google Scholar] [CrossRef] [PubMed]
  66. Vandal, O.H.; Roberts, J.A.; Odaira, T.; Schnappinger, D.; Nathan, C.F.; Ehrt, S. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J. Bacteriol. 2009, 191, 625–631. [Google Scholar] [CrossRef] [PubMed]
  67. Hett, E.C.; Chao, M.C.; Steyn, A.J.; Fortune, S.M.; Deng, L.L.; Rubin, E.J. A partner for the resuscitation-promoting factors of Mycobacterium tuberculosis. Mol. Microbiol. 2007, 66, 658–668. [Google Scholar] [CrossRef]
  68. Hett, E.C.; Chao, M.C.; Rubin, E.J. Interaction and modulation of two antagonistic cell wall enzymes of mycobacteria. PLoS Pathog. 2010, 6, e1001020. [Google Scholar] [CrossRef]
  69. Bhuwan, M.; Arora, N.; Sharma, A.; Khubaib, M.; Pandey, S.; Chaudhuri, T.K.; Hasnain, S.E.; Ehtesham, N.Z. Interaction of Mycobacterium tuberculosis Virulence Factor RipA with Chaperone MoxR1 Is Required for Transport through the TAT Secretion System. MBio 2016, 7. [Google Scholar] [CrossRef]
  70. Mukamolova, G.V.; Turapov, O.A.; Young, D.I.; Kaprelyants, A.S.; Kell, D.B.; Young, M. A family of autocrine growth factors in Mycobacterium tuberculosis. Mol Microbiol 2002, 46, 623–635. [Google Scholar] [CrossRef] [Green Version]
  71. Telkov, M.V.; Demina, G.R.; Voloshin, S.A.; Salina, E.G.; Dudik, T.V.; Stekhanova, T.N.; Mukamolova, G.V.; Kazaryan, K.A.; Goncharenko, A.V.; Young, M.; et al. Proteins of the Rpf (resuscitation promoting factor) family are peptidoglycan hydrolases. Biochemistry 2006, 71, 414–422. [Google Scholar] [CrossRef] [PubMed]
  72. Kaprelyants, A.S.; Mukamolova, G.V.; Ruggiero, A.; Makarov, V.A.; Demina, G.R.; Shleeva, M.O.; Potapov, V.D.; Shramko, P.A. Resuscitation-Promoting Factors (RPF): In Search of Inhibitors. Protein Pept. Lett. 2012, 19, 1026–1034. [Google Scholar] [CrossRef] [PubMed]
  73. Kaufmann, S.H. Tuberculosis: Deadly combination. Nature 2008, 453, 295–296. [Google Scholar] [CrossRef] [PubMed]
  74. Keep, N.H.; Ward, J.M.; Cohen-Gonsaud, M.; Henderson, B. Wake up! Peptidoglycan lysis and bacterial non-growth states. Trends Microbiol. 2006, 14, 271–276. [Google Scholar] [CrossRef] [PubMed]
  75. Mukamolova, G.V.; Kaprelyants, A.S.; Young, D.I.; Young, M.; Kell, D.B. A bacterial cytokine. Proc. Natl. Acad. Sci. USA 1998, 95, 8916–8921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Davies, A.P.; Dhillon, A.P.; Young, M.; Henderson, B.; McHugh, T.D.; Gillespie, S.H. Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue. Tuberculosis 2008, 88, 462–468. [Google Scholar] [CrossRef] [PubMed]
  77. Kana, B.D.; Gordhan, B.G.; Downing, K.J.; Sung, N.; Vostroktunova, G.; Machowski, E.E.; Tsenova, L.; Young, M.; Kaprelyants, A.; Kaplan, G.; et al. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 2008, 67, 672–684. [Google Scholar] [CrossRef]
  78. Wu, X.; Yang, Y.; Han, Y.; Zhang, J.; Liang, Y.; Li, H.; Li, B.; Wang, L. Effect of recombinant Rv1009 protein on promoting the growth of Mycobacterium tuberculosis. J. Appl. Microbiol. 2008, 105, 1121–1127. [Google Scholar] [CrossRef]
  79. Russell-Goldman, E.; Xu, J.; Wang, X.; Chan, J.; Tufariello, J.M. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 2008, 76, 4269–4281. [Google Scholar] [CrossRef]
  80. Tufariello, J.M.; Mi, K.; Xu, J.; Manabe, Y.C.; Kesavan, A.K.; Drumm, J.; Tanaka, K.; Jacobs, W.R., Jr.; Chan, J. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. Infect. Immun. 2006, 74, 2985–2995. [Google Scholar] [CrossRef]
  81. Cohen-Gonsaud, M.; Barthe, P.; Bagneris, C.; Henderson, B.; Ward, J.; Roumestand, C.; Keep, N.H. The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes. Nat. Struct. Mol. Biol. 2005, 12, 270–273. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Finley, D.; Ulrich, H.D.; Sommer, T.; Kaiser, P. The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics 2012, 192, 319–360. [Google Scholar] [CrossRef] [PubMed]
  83. Nikitushkin, V.D.; Demina, G.R.; Shleeva, M.O.; Guryanova, S.V.; Ruggiero, A.; Berisio, R.; Kaprelyants, A.S. A product of RpfB and RipA joint enzymatic action promotes the resuscitation of dormant mycobacteria. FEBS J. 2015, 282, 2500–2511. [Google Scholar] [CrossRef] [PubMed]
  84. Berisio, R.; Squeglia, F.; Ruggiero, A.; Petraccone, L.; Stellato, M.I.; Del Vecchio, P. Differential thermodynamic behaviours of the extra-cellular regions of two Ser/Thr PrkC kinases revealed by calorimetric studies. Biochim. Biophys. Acta 2015, 1854, 402–409. [Google Scholar] [CrossRef] [PubMed]
  85. Calvanese, L.; Falcigno, L.; Squeglia, F.; D’Auria, G.; Berisio, R. PASTA in Penicillin Binding Proteins and Serine/Threonine Kinases: A Recipe of Structural, Dynamic and Binding Properties. Curr. Med. Chem. 2017, 24, 4038–4056. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Ruggiero, A.; De Simone, P.; Smaldone, G.; Squeglia, F.; Berisio, R. Bacterial Cell Division Regulation by Ser/Thr Kinases: A Structural Perspective. Curr. Protein Pept. Sci. 2012, 13, 756–766. [Google Scholar] [CrossRef] [Green Version]
  87. Ruggiero, A.; Squeglia, F.; Marasco, D.; Marchetti, R.; Molinaro, A.; Berisio, R. X-ray structural studies of the entire extracellular region of the serine/threonine kinase PrkC from Staphylococcus aureus. Biochem. J. 2011, 435, 33–41. [Google Scholar] [CrossRef] [PubMed]
  88. Squeglia, F.; Marchetti, R.; Ruggiero, A.; Lanzetta, R.; Marasco, D.; Dworkin, J.; Petoukhov, M.; Molinaro, A.; Berisio, R.; Silipo, A. Chemical basis of peptidoglycan discrimination by PrkC, a key kinase involved in bacterial resuscitation from dormancy. J. Am. Chem. Soc. 2011, 133, 20676–20679. [Google Scholar] [CrossRef]
  89. Squeglia, F.; Ruggiero, A.; Berisio, R. Exit from Mycobacterial Dormancy: A Structural Perspective. Curr. Med. Chem. 2015, 22, 1698–1709. [Google Scholar] [CrossRef]
  90. Kieser, K.J.; Boutte, C.C.; Kester, J.C.; Baer, C.E.; Barczak, A.K.; Meniche, X.; Chao, M.C.; Rego, E.H.; Sassetti, C.M.; Fortune, S.M.; et al. Phosphorylation of the Peptidoglycan Synthase PonA1 Governs the Rate of Polar Elongation in Mycobacteria. PLoS Pathog. 2015, 11, e1005010. [Google Scholar] [CrossRef]
  91. Gustine, J.N.; Au, M.B.; Haserick, J.R.; Hett, E.C.; Rubin, E.J.; Gibson, F.C., 3rd; Deng, L.L. Cell Wall Hydrolytic Enzymes Enhance Antimicrobial Drug Activity Against Mycobacterium. Curr. Microbiol. 2019, 76, 398–409. [Google Scholar] [CrossRef] [PubMed]
Cells 08 00609 g001 550
Figure 1. The cytokinesis process.
Figure 1. The cytokinesis process.
Cells 08 00609 g001
Cells 08 00609 g002 550
Figure 2. Mycobacterium tuberculosis cell envelope. (A) Overall architecture of the cell envelope of Mycobacterium tuberculosis. (B) A schematic representation of peptidoglycan (PGN) along with the chemical structure of a PGN monomer.
Figure 2. Mycobacterium tuberculosis cell envelope. (A) Overall architecture of the cell envelope of Mycobacterium tuberculosis. (B) A schematic representation of peptidoglycan (PGN) along with the chemical structure of a PGN monomer.
Cells 08 00609 g002
Cells 08 00609 g003 550
Figure 3. Schematic view of all five NlpC/P60 homologs encoded in the M. tuberculosis genome.
Figure 3. Schematic view of all five NlpC/P60 homologs encoded in the M. tuberculosis genome.
Cells 08 00609 g003
Cells 08 00609 g004 550
Figure 4. Cartoon representation of the RipA catalytic domain structure. The inset shows a zoom with key residues shown with ball-and-stick.
Figure 4. Cartoon representation of the RipA catalytic domain structure. The inset shows a zoom with key residues shown with ball-and-stick.
Cells 08 00609 g004
Cells 08 00609 g005 550
Figure 5. Modeling of a PGN monomer in the catalytic site cleft of RipA (left) and main interactions of the PGN monomer with the enzyme [49].
Figure 5. Modeling of a PGN monomer in the catalytic site cleft of RipA (left) and main interactions of the PGN monomer with the enzyme [49].
Cells 08 00609 g005
Cells 08 00609 g006 550
Figure 6. Cartoon representation of the entire structure of RipA: the catalytic and pro-domains (PDB code 3ne0) are shown in orange and purple, respectively. The catalytic C383 is highlighted in dot representation. The helical domain (PDB code 6ewy) is shown in blue; the linker is shown in grey.
Figure 6. Cartoon representation of the entire structure of RipA: the catalytic and pro-domains (PDB code 3ne0) are shown in orange and purple, respectively. The catalytic C383 is highlighted in dot representation. The helical domain (PDB code 6ewy) is shown in blue; the linker is shown in grey.
Cells 08 00609 g006
Cells 08 00609 g007 550
Figure 7. Model for the activation of hydrolases by FtsX. FtsE hydrolyzes ATP to ADP upon sensing an unknown signal from inside the cell. This hydrolysis causes a conformational change that is transmitted through the membrane via FtsX. A conformational change of the extracellular part of FtsX results in interaction with either cell wall hydrolases or effector proteins and activation of PGN hydrolysis.
Figure 7. Model for the activation of hydrolases by FtsX. FtsE hydrolyzes ATP to ADP upon sensing an unknown signal from inside the cell. This hydrolysis causes a conformational change that is transmitted through the membrane via FtsX. A conformational change of the extracellular part of FtsX results in interaction with either cell wall hydrolases or effector proteins and activation of PGN hydrolysis.
Cells 08 00609 g007
Cells 08 00609 g008 550
Figure 8. Regulation of RipA via proteolytic degradation by MarP. Given the site of hydrolysis, at position V235, a successive hydrolysis is needed to activate RipA.
Figure 8. Regulation of RipA via proteolytic degradation by MarP. Given the site of hydrolysis, at position V235, a successive hydrolysis is needed to activate RipA.
Cells 08 00609 g008
Cells 08 00609 g009 550
Figure 9. Interacting partners of RipA.
Figure 9. Interacting partners of RipA.
Cells 08 00609 g009
Table
Table 1. Structural data available for septal PGN hydrolases of M. tuberculosis.
Table 1. Structural data available for septal PGN hydrolases of M. tuberculosis.
ProteinCodeFragment PDB codeRef
RipARv1477263−4723ne0,4q4g, 4q4n,4q4t[20,49]
40−2406ewy[50]
RipBRv147830−2413pbi[51]
RipDRv1566c38−1694jxb[52]
38−1824lj1[52]
RpfBRv1009194−3623eo5[25]
282−3624emn,4kl7,4kpm[23,53]
115−3625e27[24]
RpfCRv1884c68−1594ow1[54]
68−1462n5z[55]
RpfERv2450c98−1724cge[56]

Share and Cite

MDPI and ACS Style

Squeglia, F.; Moreira, M.; Ruggiero, A.; Berisio, R. The Cell Wall Hydrolytic NlpC/P60 Endopeptidases in Mycobacterial Cytokinesis: A Structural Perspective. Cells 2019, 8, 609. https://doi.org/10.3390/cells8060609

AMA Style

Squeglia F, Moreira M, Ruggiero A, Berisio R. The Cell Wall Hydrolytic NlpC/P60 Endopeptidases in Mycobacterial Cytokinesis: A Structural Perspective. Cells. 2019; 8(6):609. https://doi.org/10.3390/cells8060609

Chicago/Turabian Style

Squeglia, Flavia, Miguel Moreira, Alessia Ruggiero, and Rita Berisio. 2019. "The Cell Wall Hydrolytic NlpC/P60 Endopeptidases in Mycobacterial Cytokinesis: A Structural Perspective" Cells 8, no. 6: 609. https://doi.org/10.3390/cells8060609

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop